Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Arformoterol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 known ✓ | P07550 | 18/20 | 0.86 |
| ▸ | ADRB1 | P08588 | 6/20 | 0.86 |
| ▸ | ADRB3 | P13945 | 4/20 | 0.86 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.86 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.86 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.86 |
| ▸ | TSHR | P16473 | 3/20 | 0.86 |
| ▸ | DRD2 | P14416 | 2/20 | 0.86 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.86 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.86 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.86 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.86 |
| ▸ | PGR | P06401 | 1/20 | 0.86 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.86 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.86 |
| ▸ | DRD3 | P35462 | 1/20 | 0.86 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | RAB9A | P51151 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Arformoterol SCHEMBL7266244 | 0.96 | ADRB2 (0.79) | ADRB2ADRB1ADRB3CYP3A4MAPK1 | |
| Arformoterol SCHEMBL4536455 | 0.95 | ADRB2 (0.87) | ADRB2ADRB1ADRB3CYP3A4MAPK1 | |
| Arformoterol SCHEMBL8813649 | 0.93 | ADRB2 (0.89) | ADRB2ADRB1ADRB3CYP3A4MAPK1 | |
| Formoterol SCHEMBL6528975 | 0.93 | ADRB2 (1.00) | ADRB2ADRB1ADRB3CYP3A4MAPK1 | |
| Arformoterol SCHEMBL458736 | 0.93 | ADRB2 (1.00) | ADRB2ADRB1ADRB3CYP3A4MAPK1 | |
| Arformoterol SCHEMBL117865 | 0.93 | ADRB2 (1.00) | ADRB2ADRB1ADRB3CYP3A4MAPK1 | |
| Formoterol SCHEMBL15856256 | 0.93 | ADRB2 (1.00) | ADRB2ADRB1ADRB3CYP3A4MAPK1 | |
| Arformoterol SCHEMBL4247 | 0.93 | ADRB2 (1.00) | ADRB2ADRB1ADRB3CYP3A4MAPK1 | |
| Arformoterol SCHEMBL3679114 | 0.93 | ADRB2 (1.00) | ADRB2ADRB1ADRB3CYP3A4MAPK1 | |
| Arformoterol SCHEMBL6547706 | 0.93 | ADRB2 (1.00) | ADRB2ADRB1ADRB3CYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140066360-A1 | METHODS FOR USING SEMAPHORIN POLYPEPTIDES | UNIVERSITY OF MANITOBA (CA) | 2014-03-06 | — | — | US | disclosed |
| EP-2691107-A1 | METHODS FOR USING SEMAPHORIN POLYPEPTIDES | 2) University of Manitoba (CA) | 2014-02-05 | — | — | EP | disclosed |
| WO-2012131477-A1 | METHODS FOR USING SEMAPHORIN POLYPEPTIDES | UNIVERSITY OF MANITOBA (CA) | 2012-10-04 | — | — | WO | disclosed |
| US-20080070846-A1 | TREATING ACUTE EXACERBATIONS OF ASTHMA USING A KETOLIDE | AVENTIS PHARMACEUTICALS INC | 2008-03-20 | — | — | US | disclosed |
| EP-1819347-A1 | TREATING ACUTE EXACERBATIONS OF ASTHMA USING A KETOLIDE | Aventis Pharmaceuticals, Inc. (US) | 2007-08-22 | — | — | EP | disclosed |
| WO-2006060460-A1 | TREATING ACUTE EXACERBATIONS OF ASTHMA USING A KETOLIDE | AVENTIS PHARMACEUTICALS INC. (US) | 2006-06-08 | — | — | WO | disclosed |